- Home
- TNGX vs MGPI Comparison
TNGX vs MGPI Comparison
Compare TNGX & MGPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- MGPI
- Stock Information
- Founded
- TNGX 2014
- MGPI 1941
- Country
- TNGX United States
- MGPI United States
- Employees
- TNGX N/A
- MGPI N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- MGPI Beverages (Production/Distribution)
- Sector
- TNGX Health Care
- MGPI Consumer Staples
- Exchange
- TNGX Nasdaq
- MGPI Nasdaq
- Market Cap
- TNGX 351.2M
- MGPI 626.9M
- IPO Year
- TNGX N/A
- MGPI 1988
- Fundamental
- Price
- TNGX $6.01
- MGPI $31.18
- Analyst Decision
- TNGX Strong Buy
- MGPI Strong Buy
- Analyst Count
- TNGX 6
- MGPI 5
- Target Price
- TNGX $12.20
- MGPI $45.40
- AVG Volume (30 Days)
- TNGX 2.7M
- MGPI 272.4K
- Earning Date
- TNGX 08-06-2025
- MGPI 07-31-2025
- Dividend Yield
- TNGX N/A
- MGPI 1.54%
- EPS Growth
- TNGX N/A
- MGPI N/A
- EPS
- TNGX N/A
- MGPI 0.50
- Revenue
- TNGX $40,990,000.00
- MGPI $654,715,000.00
- Revenue This Year
- TNGX N/A
- MGPI N/A
- Revenue Next Year
- TNGX N/A
- MGPI N/A
- P/E Ratio
- TNGX N/A
- MGPI $62.22
- Revenue Growth
- TNGX 10.09
- MGPI N/A
- 52 Week Low
- TNGX $1.03
- MGPI $25.12
- 52 Week High
- TNGX $12.02
- MGPI $92.52
- Technical
- Relative Strength Index (RSI)
- TNGX 76.36
- MGPI 53.11
- Support Level
- TNGX $5.34
- MGPI $30.64
- Resistance Level
- TNGX $6.40
- MGPI $33.38
- Average True Range (ATR)
- TNGX 0.50
- MGPI 1.13
- MACD
- TNGX -0.02
- MGPI 0.11
- Stochastic Oscillator
- TNGX 84.08
- MGPI 51.00
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.